- Home
- LYEL vs SANG Comparison
LYEL vs SANG Comparison
Compare LYEL & SANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYEL
- SANG
- Stock Information
- Founded
- LYEL 2018
- SANG 1984
- Country
- LYEL United States
- SANG Canada
- Employees
- LYEL N/A
- SANG N/A
- Industry
- LYEL Biotechnology: Pharmaceutical Preparations
- SANG Computer Software: Programming Data Processing
- Sector
- LYEL Health Care
- SANG Technology
- Exchange
- LYEL Nasdaq
- SANG Nasdaq
- Market Cap
- LYEL 207.7M
- SANG 194.3M
- IPO Year
- LYEL 2021
- SANG 2021
- Fundamental
- Price
- LYEL $10.76
- SANG $5.74
- Analyst Decision
- LYEL Sell
- SANG
- Analyst Count
- LYEL 2
- SANG 0
- Target Price
- LYEL $15.00
- SANG N/A
- AVG Volume (30 Days)
- LYEL 47.2K
- SANG 1.6K
- Earning Date
- LYEL 08-12-2025
- SANG 09-17-2025
- Dividend Yield
- LYEL N/A
- SANG N/A
- EPS Growth
- LYEL N/A
- SANG N/A
- EPS
- LYEL N/A
- SANG N/A
- Revenue
- LYEL $60,000.00
- SANG $238,264,000.00
- Revenue This Year
- LYEL N/A
- SANG N/A
- Revenue Next Year
- LYEL N/A
- SANG $2.38
- P/E Ratio
- LYEL N/A
- SANG N/A
- Revenue Growth
- LYEL 11.11
- SANG N/A
- 52 Week Low
- LYEL $7.65
- SANG $4.08
- 52 Week High
- LYEL $32.40
- SANG $7.99
- Technical
- Relative Strength Index (RSI)
- LYEL 49.97
- SANG 47.96
- Support Level
- LYEL $10.49
- SANG $5.65
- Resistance Level
- LYEL $11.00
- SANG $5.80
- Average True Range (ATR)
- LYEL 0.72
- SANG 0.08
- MACD
- LYEL -0.11
- SANG 0.00
- Stochastic Oscillator
- LYEL 52.86
- SANG 68.75
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.